Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine in Postoperative Ileus
NCT00676377Phase 4Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of neostigmine in postoperative ileus (POI) and acute colonic pseudo-obstruction (ACPO), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoint: Rate of postoperative ileus at 6 hours. Started Aug 2007; status: completed.
02
Drugs
neostigmine
03
Conditions
postoperative ileus (POI)acute colonic pseudo-obstruction (ACPO)
Beyond the preview
Go deeper on NCT00676377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676377.